Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.56 | 1.44 |
NAV | ₹89.67 | ₹108.00 |
Fund Started | 12 Jun 2007 | 08 Apr 2008 |
Fund Size | ₹35313.48 Cr | ₹63938.03 Cr |
Exit Load | Exit load of 1% if redeemed within 7 days. | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 27.49% | 25.75% |
3 Year | 21.11% | 18.07% |
5 Year | 20.97% | 19.92% |
1 Year
3 Year
5 Year
Equity | 98.76% | 90.91% |
Cash | 1.23% | 8.73% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.64% |
ICICI Bank Ltd. | 6.44% |
Reliance Industries Ltd. | 5.70% |
ITC Ltd. | 5.41% |
Infosys Ltd. | 4.38% |
State Bank of India | 4.14% |
Larsen & Toubro Ltd. | 3.82% |
Axis Bank Ltd. | 3.74% |
Bajaj Finance Ltd. | 3.03% |
Tata Power Company Ltd. | 2.90% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 8.54% |
ICICI Bank Ltd. | 8.22% |
Larsen & Toubro Ltd. | 6.49% |
Infosys Ltd. | 4.63% |
Reliance Industries Ltd. | 4.46% |
Bharti Airtel Ltd. | 4.18% |
Axis Bank Ltd. | 4.12% |
Maruti Suzuki India Ltd. | 4.04% |
Ultratech Cement Ltd. | 3.76% |
Sun Pharmaceutical Industries Ltd. | 2.92% |
Name | Akshay Sharma | Vaibhav Dusad |
Start Date | 01 Dec 2022 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly into equity and equity related instruments of large cap companies. | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 12 Jun 2007 | 08 Apr 2008 |
Description
Launch Date